when there is issues with cavalabs, working through GMP and getting cannepil to Australia it is always good to see management take some time out of there busy schedule to orgainise some very generious share plans for them selves. Issue price of 12.5c is just taking the mikey considering we only touched on that price earlier this year.
- Forums
- ASX - By Stock
- RGT
- Ann: Issue of Unlisted Options - Appendix 3B
Ann: Issue of Unlisted Options - Appendix 3B, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
29.0¢ |
Change
-0.025(7.94%) |
Mkt cap ! $13.13M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 29.0¢ | $688 | 2.372K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1033 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 52766 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1033 | 0.290 |
1 | 1184 | 0.285 |
1 | 2500 | 0.280 |
1 | 9600 | 0.275 |
1 | 10000 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 52766 | 2 |
0.315 | 2825 | 2 |
0.335 | 8000 | 1 |
0.340 | 44885 | 3 |
0.360 | 4100 | 1 |
Last trade - 11.01am 03/07/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online